You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 28, 2025

List of Excipients in API valganciclovir


✉ Email this page to a colleague

« Back to Dashboard


Excipients in NDA-approved (novel) drugs containing valganciclovir

Glossary
Company Tradename Ingredient NDC Excipient Potential Generic Entry
Genentech Inc VALCYTE valganciclovir 0004-0038 CELLULOSE, MICROCRYSTALLINE
Genentech Inc VALCYTE valganciclovir 0004-0038 CROSPOVIDONE
Genentech Inc VALCYTE valganciclovir 0004-0038 FERRIC OXIDE RED
Genentech Inc VALCYTE valganciclovir 0004-0038 HYPROMELLOSE 2910
Genentech Inc VALCYTE valganciclovir 0004-0038 POLYETHYLENE GLYCOL 400
Genentech Inc VALCYTE valganciclovir 0004-0038 POLYSORBATE 80
>Company >Tradename >Ingredient >NDC >Excipient >Potential Generic Entry

Subscribe to access the full database, or Get Started Free

Excipients in ANDA-approved (generic) drugs containing valganciclovir

Company Ingredient NDC Excipient
Major Pharmaceuticals valganciclovir 0904-6796 CELLULOSE, MICROCRYSTALLINE
Major Pharmaceuticals valganciclovir 0904-6796 CROSPOVIDONE
Major Pharmaceuticals valganciclovir 0904-6796 FERRIC OXIDE RED
Major Pharmaceuticals valganciclovir 0904-6796 HYPROMELLOSE
Major Pharmaceuticals valganciclovir 0904-6796 POLYETHYLENE GLYCOL
Major Pharmaceuticals valganciclovir 0904-6796 POLYSORBATE 80
>Company >Ingredient >NDC >Excipient

Subscribe to access the full database, or Get Started Free

Detailed excipient profiles for valganciclovir

Excipient focus: .ALPHA.-TOCOPHEROL

Excipient focus: ACACIA

Excipient focus: ANHYDROUS CITRIC ACID

Excipient focus: CELLULOSE, MICROCRYSTALLINE

valganciclovir drug variants not containing CELLULOSE, MICROCRYSTALLINE

Company Ingredient NDC
Granules Pharmaceuticals Inc valganciclovir 70010-051
Somerset Therapeutics LLC valganciclovir 70069-810
airis PHARMA PVT LTD valganciclovir 71151-003
Florida Pharmaceutical Products LLC valganciclovir 71921-210
Actavis Pharma Inc valganciclovir hydrochloride 0591-2579
MAJOR PHARMACEUTICALS valganciclovir hydrochloride 0904-7419
>Company >Ingredient >NDC

Subscribe to access the full database, or Get Started Free

Excipient focus: CROSPOVIDONE

Excipient focus: FERRIC OXIDE RED

valganciclovir drug variants not containing FERRIC OXIDE RED

Company Ingredient NDC
Granules Pharmaceuticals Inc valganciclovir 70010-051
Somerset Therapeutics LLC valganciclovir 70069-810
airis PHARMA PVT LTD valganciclovir 71151-003
Florida Pharmaceutical Products LLC valganciclovir 71921-210
Actavis Pharma Inc valganciclovir hydrochloride 0591-2579
MAJOR PHARMACEUTICALS valganciclovir hydrochloride 0904-7419
>Company >Ingredient >NDC

Subscribe to access the full database, or Get Started Free

Excipient focus: FERRIC OXIDE YELLOW

Excipient focus: FUMARIC ACID

Excipient focus: HYPROMELLOSE

Excipient focus: HYPROMELLOSE 2910

Excipient focus: HYPROMELLOSES

Excipient focus: MAGNESIUM STEARATE

Excipient focus: MALTODEXTRIN

Excipient focus: MANNITOL

Excipient focus: OCTENYLSUCCINIC ACID

Excipient focus: POLYETHYLENE GLYCOL

Excipient focus: POLYETHYLENE GLYCOL 400

Excipient focus: POLYETHYLENE GLYCOL 4000

valganciclovir drug variants containing POLYETHYLENE GLYCOL 4000

Company Ingredient NDC
Par Pharmaceutical valganciclovir hydrochloride 0603-6330
AvKARE valganciclovir hydrochloride 42291-875
AvKARE valganciclovir hydrochloride 42291-973
Bryant Ranch Prepack valganciclovir hydrochloride 63629-2288
Strides Pharma Science Limited valganciclovir hydrochloride 64380-153
Strides Pharma Science Limited valganciclovir hydrochloride 64380-161
>Company >Ingredient >NDC

Subscribe to access the full database, or Get Started Free

Excipient focus: POLYETHYLENE GLYCOL 6000

Excipient focus: POLYSORBATE 80

Excipient focus: POLYVINYL ALCOHOL

valganciclovir drug variants containing POLYVINYL ALCOHOL

Company Ingredient NDC
Par Pharmaceutical valganciclovir hydrochloride 0603-6330
AvKARE valganciclovir hydrochloride 42291-875
AvKARE valganciclovir hydrochloride 42291-973
Bryant Ranch Prepack valganciclovir hydrochloride 63629-2288
Strides Pharma Science Limited valganciclovir hydrochloride 64380-153
Strides Pharma Science Limited valganciclovir hydrochloride 64380-161
>Company >Ingredient >NDC

Subscribe to access the full database, or Get Started Free

Excipient focus: POVIDONE

Excipient focus: POVIDONE K30

Excipient focus: PROPYLENE GLYCOL

Excipient focus: SACCHARIN SODIUM

valganciclovir drug variants containing SACCHARIN SODIUM

Company Ingredient NDC
airis PHARMA PVT LTD valganciclovir 71151-003
MAJOR PHARMACEUTICALS valganciclovir hydrochloride 0904-7419
Ajanta Pharma USA Inc valganciclovir hydrochloride 27241-159
Camber Pharmaceuticals Inc valganciclovir hydrochloride 31722-837
American Health Packaging valganciclovir hydrochloride 60687-765
Novadoz Pharmaceuticals LLC valganciclovir hydrochloride 72205-019
>Company >Ingredient >NDC

Subscribe to access the full database, or Get Started Free

Excipient focus: SILICON DIOXIDE

valganciclovir drug variants containing SILICON DIOXIDE

Company Ingredient NDC
Par Pharmaceutical valganciclovir hydrochloride 0603-6330
Ajanta Pharma USA Inc valganciclovir hydrochloride 27241-159
AvKARE valganciclovir hydrochloride 42291-875
AvKARE valganciclovir hydrochloride 42291-973
Dr Reddy's Laboratories Inc valganciclovir hydrochloride 43598-356
Bryant Ranch Prepack valganciclovir hydrochloride 63629-2288
>Company >Ingredient >NDC

Subscribe to access the full database, or Get Started Free

Excipient focus: SODIUM BENZOATE

Excipient focus: STEARIC ACID

Excipient focus: SUCRALOSE

Excipient focus: TALC

valganciclovir drug variants containing TALC

Company Ingredient NDC
Par Pharmaceutical valganciclovir hydrochloride 0603-6330
AvKARE valganciclovir hydrochloride 42291-875
AvKARE valganciclovir hydrochloride 42291-973
Bryant Ranch Prepack valganciclovir hydrochloride 63629-2288
Strides Pharma Science Limited valganciclovir hydrochloride 64380-153
Strides Pharma Science Limited valganciclovir hydrochloride 64380-161
>Company >Ingredient >NDC

Subscribe to access the full database, or Get Started Free

Excipient focus: TARTARIC ACID

Excipient focus: TITANIUM DIOXIDE

valganciclovir drug variants not containing TITANIUM DIOXIDE

Company Ingredient NDC
Granules Pharmaceuticals Inc valganciclovir 70010-051
Somerset Therapeutics LLC valganciclovir 70069-810
airis PHARMA PVT LTD valganciclovir 71151-003
Florida Pharmaceutical Products LLC valganciclovir 71921-210
Actavis Pharma Inc valganciclovir hydrochloride 0591-2579
MAJOR PHARMACEUTICALS valganciclovir hydrochloride 0904-7419
>Company >Ingredient >NDC

Subscribe to access the full database, or Get Started Free

Excipient focus: TRIACETIN

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2025 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2025 - 2026
 NCE-1 Patent Challenge Dates 2025 - 2026
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2025, www.DrugPatentWatch.com.
   See Primary Research Papers Citing DrugPatentWatch

Links